Key Takeaways:
Remy Cointreau reported fiscal first-quarter organic sales of €223.2 million ($254.5 million), beating consensus estimates of €218.8 million.
The company said the results were supported by strong momentum in Asia-Pacific markets outside China, which helped offset ongoing weakness in the U.S. and China, according to its earnings statement. Remy is seeking to rebuild growth after a prolonged downturn caused by U.S. distributor destocking and weak demand in China.
Cognac division organic sales rose 7.7%, well above the 1.3% increase analysts had expected. The liqueurs and spirits division fell 6.6% organically, compared with expectations for a 1.5% decline, as unfavorable shipment timing in the United States weighed on performance. The company did not disclose earnings per share or segment-level profit figures.
The cognac rebound is a key milestone for Remy, which generates a significant portion of its profit from the high-end brandy. The company maintained its full-year targets, signaling confidence that its recovery plan is on track despite ongoing headwinds in China and the U.S.
The performance contrasts with larger rival Pernod Ricard, which has also faced challenges in China, and LVMH's Hennessy cognac business, which has been navigating similar demand shifts in the region. Remy's Asia-Pacific exposure outside China has provided a buffer as the company works through U.S. inventory destocking that began in late 2023.
The cognac rebound signals that Remy's efforts to reignite demand in Asia are gaining traction, particularly in markets such as Japan, South Korea, and Southeast Asia. Investors will watch the next quarterly update for signs of a recovery in the U.S. market and further momentum during the key Chinese New Year selling season.
This article is for informational purposes only and does not constitute investment advice.
